Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
12
2018
accepted:
22
07
2019
entrez:
2
8
2019
pubmed:
2
8
2019
medline:
10
3
2020
Statut:
epublish
Résumé
Although vaccination against influenza is recommended for pregnant women in France because it exposes them to a risk of death and severe respiratory complications, their vaccination coverage in 2016 was estimated at 7%. This study's principal objective was to assess the association between the availability of influenza vaccination at prenatal care visits and vaccination coverage. This multicenter survey took place in 3 Paris-area public hospital (AP-HP) maternity wards (A, B, and C). Only maternity ward A offered the vaccine and vaccination without charge at prenatal visits. Data were collected from parturients during 10 days in January 2017 by a self-administered anonymous questionnaire. Data from 248 women showed overall vaccination coverage of 19.4% (48/248): 35.4% (46/130) in maternity unit A, 2.7% (2/75) in B, and 0% (0/43) in C (P<0.01). After adjustment for socio-demographic characteristics, women at maternity ward A were significantly more likely to be vaccinated than those at B and C (aOR 25.52, 95%CI [5.76-113.10]). Other factors significantly associated with higher vaccination coverage were the mother's French birth (aOR 2.37 CI [1.03-5.46]) and previous influenza vaccination (aOR 3.13, 95%CI [1.25-7.86]). Vaccinated women generally considered they had received adequate information (aOR 4.15 CI [2.10-8.22]), principally from the professional providing their prenatal care. Nonvaccination was attributed to the absence of an offer of vaccination (81.5%), fear of fetal side effects (59.5%), and inadequate information (51.4%). Our results show that availability of influenza vaccination, free of charge, at prenatal consultations at the maternity ward increases vaccination coverage significantly.
Identifiants
pubmed: 31369626
doi: 10.1371/journal.pone.0220705
pii: PONE-D-18-27502
pmc: PMC6675112
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0220705Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Epidemiol. 2006 Mar 15;163(6):571-8
pubmed: 16443801
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552
Vaccine. 2009 Jun 19;27(30):4018-24
pubmed: 19389442
Obstet Gynecol. 2010 Apr;115(4):717-26
pubmed: 20308830
JAMA. 2010 Apr 21;303(15):1517-25
pubmed: 20407061
N Engl J Med. 2010 Apr 29;362(17):1644-6
pubmed: 20427817
J Am Geriatr Soc. 2010 Jul;58(7):1333-40
pubmed: 20533970
Health Technol Assess. 2010 Jul;14(34):109-82
pubmed: 20630123
Arch Pediatr Adolesc Med. 2011 Feb;165(2):104-11
pubmed: 20921345
J Obstet Gynaecol Can. 2010 Aug;32(8):745-8
pubmed: 21050505
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S112-5
pubmed: 21345408
J Obstet Gynaecol Can. 2011 May;33(5):460-467
pubmed: 21639966
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S1-3
pubmed: 21640228
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S124-7
pubmed: 21640229
PLoS Med. 2011 May;8(5):e1000441
pubmed: 21655318
BMJ. 2011 Jun 14;342:d3214
pubmed: 21672992
PLoS One. 2011;6(6):e20900
pubmed: 21695074
Am J Obstet Gynecol. 2011 Nov;205(5):473.e1-9
pubmed: 21861964
Matern Child Health J. 2013 Jan;17(1):23-32
pubmed: 22297574
J Matern Fetal Neonatal Med. 2012 Sep;25(9):1800-9
pubmed: 22339083
Vaccine. 2012 Apr 16;30(18):2892-9
pubmed: 22374374
N Engl J Med. 2013 Jan 24;368(4):333-40
pubmed: 23323868
Obstet Gynecol. 2013 Mar;121(3):519-25
pubmed: 23635613
Presse Med. 2013 Nov;42(11):1453-60
pubmed: 23683385
Vaccine. 2013 Oct 25;31(45):5281-8
pubmed: 24016814
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
N Engl J Med. 2014 Sep 4;371(10):918-31
pubmed: 25184864
Expert Opin Drug Saf. 2014 Dec;13(12):1709-20
pubmed: 25363497
Clin Infect Dis. 2015 Mar 1;60(5):e11-9
pubmed: 25409473
Hum Vaccin Immunother. 2015;11(3):713-8
pubmed: 25714987
J Womens Health (Larchmt). 2015 May;24(5):394-402
pubmed: 25874550
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
Women Birth. 2016 Oct;29(5):423-429
pubmed: 26879102
Lancet Infect Dis. 2016 Sep;16(9):1026-1035
pubmed: 27261067
Vaccine. 2016 Jul 25;34(34):3942-9
pubmed: 27317458
PLoS One. 2016 Jul 08;11(7):e0159087
pubmed: 27391098
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
BMC Infect Dis. 2017 Jan 9;17(1):48
pubmed: 28068918
Lancet Infect Dis. 2017 Sep;17(9):981-989
pubmed: 28522338
Public Health Rep. 2017 Jul/Aug;132(4):451-454
pubmed: 28586623
Vaccine. 2018 Oct 22;36(44):6473-6479
pubmed: 28811050
MMWR Morb Mortal Wkly Rep. 2017 Sep 29;66(38):1016-1022
pubmed: 28957044
Vaccine. 2018 Mar 20;36(13):1796-1800
pubmed: 29395531
Vaccine. 2018 Mar 27;36(14):1801-1803
pubmed: 29506923
Hum Vaccin Immunother. 2018 Jul 3;14(7):1558-1565
pubmed: 29641945
Hum Vaccin Immunother. 2018 Jul 3;14(7):1573-1579
pubmed: 29863958
PLoS One. 2018 Jun 14;13(6):e0197867
pubmed: 29902184
Med Mal Infect. 2019 Feb;49(1):34-37
pubmed: 30409542
Vaccine. 2019 Feb 8;37(7):984-990
pubmed: 30655175
PLoS One. 2019 Mar 28;14(3):e0214538
pubmed: 30921421